Olive Leaf Extract Downregulates the Protein Expression of Key SARS‐CoV‐2 Entry Enzyme ACE‐2, TMPRSS2, and Furin
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202400717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Abdurrahim Kocyigit und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bezmialem Vakıf University, Faculty of Medicine, Department of Medical Biochemistry, Istanbul, Turkey. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Serine Endopeptidases, Furin, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Bezmialem Vakif University Scientific Research Projects Units.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) poses ongoing global health challenges due to its propensity for mutations, which can undermine vaccine efficacy. With no definitive treatment available, urgent research into affordable and biocompatible therapeutic agents is extremely urgent. Angiotensin converting enzyme‐2 (ACE‐2), transmembrane protease serine subtype 2 (TMPRSS2), and Furin enzymes, which allow the virus to enter cells, are particularly important as potential drug targets among scientists. Olive leaf extract (OLE) has garnered attention for its potential against Coronavirus Disease‐9 (COVID‐19), yet its mechanism remains understudied. In this study, we aimed to investigate the effects of OLE on ACE‐2, TMPRSS2, and Furin protein expressions by cell culture study. Total phenol, flavonoid content, and antioxidant capacity were measured by photometric methods, and oleuropein levels were measured by liquid LC‐HR‐MS. Cell viability was analyzed by ATP levels using a luminometric method. ACE‐2, TMPRSS2, and Furin expressions were analyzed by the Western Blotting method. ACE‐2, TMPRSS2, and Furin protein expression levels were significantly lower in a dose dependent manner and the highest inhibition was seen at 100 μg/ml OLE. The results showed that OLE may be a promising treatment candidate for COVID‐19 disease. However, further studies need to be conducted in cells co‐infected with the virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bezmialem Vakıf University, Faculty of Medicine, Department of Medical Biochemistry, Istanbul, Turkey.
- Bezmialem Vakif University, Traditional and Complementary Medicine Advanced Research Applications and Research Center, Istanbul, Turkey.
- Bezmialem Vakif University, Vocational School of Health Services, Istanbul, Turkey.
- Bezmialem Vakıf University, Institute of Health Sciences, Medical Biochemistry, Turkey.
ORCID-Profile: Abdurrahim Kocyigit, Ebru Kanımdan, Vildan Betul Yenigun, Zeynep Ozman, Fatmanur Babalı Balıbey, Ezgi Durmuş, Oznur Yasar
Förderung
- Bezmialem Vakif University Scientific Research Projects Units
Zitieren
APA
Kocyigit, A., Kanımdan, E., Yenigun, V. B., Ozman, Z., Balıbey, F. B., Durmuş, E., & Yasar, O. (2024). Olive Leaf Extract Downregulates the Protein Expression of Key SARS‐CoV‐2 Entry Enzyme ACE‐2, TMPRSS2, and Furin. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400717
Vancouver
Kocyigit A, Kanımdan E, Yenigun VB, Ozman Z, Balıbey FB, Durmuş E, et al. Olive Leaf Extract Downregulates the Protein Expression of Key SARS‐CoV‐2 Entry Enzyme ACE‐2, TMPRSS2, and Furin. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400717
BibTeX
@article{Kocyigit2024,
author = {Kocyigit, Abdurrahim and Kanımdan, Ebru and Yenigun, Vildan Betul and Ozman, Zeynep and Balıbey, Fatmanur Babalı and Durmuş, Ezgi and Yasar, Oznur},
title = {Olive Leaf Extract Downregulates the Protein Expression of Key SARS‐CoV‐2 Entry Enzyme ACE‐2, TMPRSS2, and Furin},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202400717}
}
EUVIMED